Möchten Sie immer auf dem neuesten Stand bleiben?

Company-issued report examining Ever Joint ingredient research, dosing transparency, oxidative stress claims, and consumer verification steps.

ITASCA, Ill., March 18, 2026 (GLOBE NEWSWIRE) -- Riverside Insights, a leading provider of trusted, research-backed assessments, today announced the acquisition of Move This World, a proactive...

AI-powered autonomous research agents to be deployed in support of PEX010 clinical development strategy, leveraging Kala Bio’s purpose-built agentic AI platform for the biotechnology industry TORONTO...

STAFFORD, Texas, March 18, 2026 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial,...

SAN DIEGO, March 17, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics (NASDAQ: BNGO) participated in the 2026 American College of Medical Genetics and Genomics Annual Meeting (ACMG), held March 14–18 in...

NORCROSS, Ga., March 17, 2026 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of galectin-3-targeted therapeutics for patients with MASH cirrhosis and portal...

LOS ANGELES, March 16, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises NuScale Power Corporation, (“NuScale” or the "Company") (NYSE: SMR) investors off a class action on behalf of investors...

The case alleges that NuScale failed to disclose that it entrusted its NPM commercialization to an entity that lacked significant prior experience.

Washington, D.C., March 12, 2026 (GLOBE NEWSWIRE) -- Animal Wellness Action, the Center for a Humane Economy, key Audubon organizations across New York, and more than 15 other organizations today...

Dublin, March 12, 2026 (GLOBE NEWSWIRE) -- The "Psychedelic Drugs Market: Industry Trends and Global Forecasts - Distribution by Origin of Substance, Type of Psychedelic Substance, Target Disease...